Atai Beckley Inc. (ATAI)
$7.35+0.00%Close
BUYBULL · day 36
Key stats
- Market cap
- $2.7B
- Beta
- 1.55
- Div yield
- 91.84%
- P/E (TTM)
- -2.53
- 1W
- +0.14%
- 1M
- +1.66%
- vs SPY 1W
- -0.29%
- vs SPY 1M
- -0.40%
Industry peers
FMP comparable companies · ranked by market cap
- DNTHSELLDianthus Therapeutics, Inc.$4.6BCRISISQ 2$82.37-0.97%
- RLAYSELLRelay Therapeutics, Inc.$3.9BRECOVERYQ 3$17.88+0.56%
- AMLXSELLAmylyx Pharmaceuticals, Inc.$3.1BRECOVERYQ 7$28.14-2.35%
- ELVNSELLEnliven Therapeutics, Inc.$2.9BCRISISQ 11$40.98-0.34%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.5BCRISISQ 16$16.99-2.59%
- INBXSELLInhibrx Biosciences Inc.$1.4BCRISISQ 32$95.01-4.72%
- ORICSELLORIC Pharmaceuticals, Inc.$1.2BBEARQ 3$11.99-1.50%
- NKTRSELLNektar Therapeutics$1.2BCRISISQ 12$41.17-3.23%
- IMTXSELLImmatics N.V.$996MCRISISQ 6$7.43-2.96%
- SANASELLSana Biotechnology, Inc.$776MCRISISQ -6$2.79-6.09%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ATAI?
- LOPJLB’s latest quantitative signal on Atai Beckley Inc. (ATAI) is BUY in a BULL regime. Signals are updated daily.
- What market regime is ATAI in?
- Atai Beckley Inc. (ATAI) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Atai Beckley Inc. (ATAI) do?
- Atai Beckley Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of innovative therapeutic solutions for a variety of mental health conditions. The company's operations extend across the United States, Germany, and Canada. Its development pipeline features several key compounds: BPL-003: An intranasally administered formulation…